6 studies found for:    8423228 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
Condition: Type 2 Diabetes Mellitus
Intervention: Biological: Glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2)
2 Recruiting Investigating the Incretin Effect in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Oral Glucose Tolerance test (75g 2-hour);   Drug: Modified Oral Glucose Tolerance Test (50g 4-hours);   Drug: Matched isoglycemic clamp;   Drug: Hyperglycemic clamp with concurrent GLP-1 infusion;   Drug: Hyperglycemic Clamp with concurrent GIP infusion;   Drug: Hyperglycemic clamp with placebo infusion;   Other: Liquid Meal Test (Carbohydrate-rich);   Other: Liquid Meal Test (Fat-rich);   Other: Liquid Meal Test (Mixed);   Device: Continuous Glucose Monitoring
3 Completed GIP: Glucose-dependent Insulinotropic Peptide
Condition: Type 2 Diabetes
Interventions: Drug: GIP;   Drug: Modified GIP;   Drug: Normal Saline
4 Completed
Has Results
Physical Training and the Incretin Effect
Condition: Healthy
Intervention:
5 Not yet recruiting Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
Conditions: Gastroparesis;   Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Placebo
6 Completed Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
Condition: Hypoglycaemia
Interventions: Drug: GLP-1;   Drug: Placebo (Saline);   Drug: TNF-alfa;   Other: OGTT;   Other: IVGTT

Indicates status has not been verified in more than two years